Surprisingly, genes centered on EVPL and ENTPD3 in the network were co-enriched in the regulation of immune cells and immune responses, pointing to the important role that EVPL- and ENTPD3-related immune dysregulation may play in the co-progression of T2DM and CRC. The gene discussed is ENTPD3; the disease is colorectal carcinoma.